ID   CATK_HUMAN              Reviewed;         329 AA.
AC   P43235; Q6FHS6;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   10-MAY-2017, entry version 179.
DE   RecName: Full=Cathepsin K;
DE            EC=3.4.22.38;
DE   AltName: Full=Cathepsin O;
DE   AltName: Full=Cathepsin O2;
DE   AltName: Full=Cathepsin X;
DE   Flags: Precursor;
GN   Name=CTSK; Synonyms=CTSO, CTSO2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Blood;
RX   PubMed=7805878; DOI=10.1016/0014-5793(94)01349-6;
RA   Shi G.-P., Chapman H.A., Bhairi S.M., Deleeuw C., Reddy V.Y.,
RA   Weiss S.J.;
RT   "Molecular cloning of human cathepsin O, a novel endoproteinase and
RT   homologue of rabbit OC2.";
RL   FEBS Lett. 357:129-134(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Bone;
RX   PubMed=7818555; DOI=10.1006/bbrc.1995.1013;
RA   Inaoka T., Bilbe G., Ishibashi O., Tezuka K., Kumegawa M., Kokubo T.;
RT   "Molecular cloning of human cDNA for cathepsin K: novel cysteine
RT   proteinase predominantly expressed in bone.";
RL   Biochem. Biophys. Res. Commun. 206:89-96(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Osteoclastoma;
RX   PubMed=8585423; DOI=10.1002/jbmr.5650100809;
RA   Li Y., Alexander M., Wucherpfennig A.L., Yelick P., Chen W.,
RA   Stashenko P.;
RT   "Cloning and complete coding sequence of a novel human cathepsin
RT   expressed in giant cells of osteoclastomas.";
RL   J. Bone Miner. Res. 10:1197-1202(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Spleen;
RX   PubMed=7576232; DOI=10.1515/bchm3.1995.376.6.379;
RA   Broemme D., Okamoto K.;
RT   "Human cathepsin O2, a novel cysteine protease highly expressed in
RT   osteoclastomas and ovary molecular cloning, sequencing and tissue
RT   distribution.";
RL   Biol. Chem. Hoppe-Seyler 376:379-384(1995).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS).
RX   PubMed=9033587; DOI=10.1038/nsb0297-105;
RA   McGrath M.E., Klaus J.L., Barnes M.G., Bromme D.;
RT   "Crystal structure of human cathepsin K complexed with a potent
RT   inhibitor.";
RL   Nat. Struct. Biol. 4:105-109(1997).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS).
RX   PubMed=9405598; DOI=10.1073/pnas.94.26.14249;
RA   Thompson S.K., Halbert S.M., Bossard M.J., Tomaszek T.A., Levy M.A.,
RA   Zhao B., Smith W.W., Abdel-Meguid S.S., Janson C.A., D'Alessio K.J.,
RA   McQueney M.S., Amegadzie B.Y., Hanning C.R., Desjarlais R.L.,
RA   Briand J., Sarkar S.K., Huddleston M.J., Ijames C.F., Carr S.A.,
RA   Garnes K.T., Shu A., Heys J.R., Bradbeer J., Zembryki D., Veber D.F.;
RT   "Design of potent and selective human cathepsin K inhibitors that span
RT   the active site.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:14249-14254(1997).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF ZYMOGEN FORM.
RX   PubMed=9893980; DOI=10.1021/bi9822271;
RA   LaLonde J.M., Zhao B., Janson C.A., D'Alessio K.J., McQueney M.S.,
RA   Orsini M.J., Debouck C.M., Smith W.W.;
RT   "The crystal structure of human procathepsin K.";
RL   Biochemistry 38:862-869(1999).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (3.2 ANGSTROMS).
RX   PubMed=10048321; DOI=10.1110/ps.8.2.283;
RA   Sivaraman J., Lalumiere M., Menard R., Cygler M.;
RT   "Crystal structure of wild-type human procathepsin K.";
RL   Protein Sci. 8:283-290(1999).
RN   [13]
RP   VARIANT PKND ARG-146.
RX   PubMed=8703060; DOI=10.1126/science.273.5279.1236;
RA   Gelb B.D., Shi G.-P., Chapman H.A., Desnick R.J.;
RT   "Pycnodysostosis, a lysosomal disease caused by cathepsin K
RT   deficiency.";
RL   Science 273:1236-1238(1996).
RN   [14]
RP   VARIANT PKND VAL-277.
RX   PubMed=9529353; DOI=10.1086/301795;
RA   Gelb B.D., Willner J.P., Dunn T.M., Kardon N.B., Verloes A.,
RA   Poncin J., Desnick R.J.;
RT   "Paternal uniparental disomy for chromosome 1 revealed by molecular
RT   analysis of a patient with pycnodysostosis.";
RL   Am. J. Hum. Genet. 62:848-854(1998).
RN   [15]
RP   VARIANT PKND GLU-79.
RX   PubMed=10491211; DOI=10.1359/jbmr.1999.14.10.1649;
RA   Ho N., Punturieri A., Wilkin D., Szabo J., Johnson M., Whaley J.,
RA   Davis J., Clark A., Weiss S., Francomano C.;
RT   "Mutations of CTSK result in pycnodysostosis via a reduction in
RT   cathepsin K protein.";
RL   J. Bone Miner. Res. 14:1649-1653(1999).
RN   [16]
RP   VARIANTS PKND GLU-79 AND PRO-309.
RX   PubMed=10878663; DOI=10.1038/sj.ejhg.5200481;
RA   Haagerup A., Hertz J.M., Christensen M.F., Binderup H., Kruse T.A.;
RT   "Cathepsin K gene mutations and 1q21 haplotypes in at patients with
RT   pycnodysostosis in an outbred population.";
RL   Eur. J. Hum. Genet. 8:431-436(2000).
RN   [17]
RP   VARIANTS PKND PRO-122 AND VAL-277.
RX   PubMed=22822386;
RA   Matsushita M., Kitoh H., Kaneko H., Mishima K., Itoh Y., Hattori T.,
RA   Ishiguro N.;
RT   "Novel Compound Heterozygous Mutations in the Cathepsin K Gene in
RT   Japanese Female Siblings with Pyknodysostosis.";
RL   Mol. Syndromol. 2:254-258(2012).
RN   [18]
RP   VARIANT PKND CYS-283, AND CHARACTERIZATION OF VARIANT PKND CYS-283.
RX   PubMed=25731711; DOI=10.1177/0022034515573964;
RA   Xue Y., Wang L., Xia D., Li Q., Gao S., Dong M., Cai T., Shi S.,
RA   He L., Hu K., Mao T., Duan X.;
RT   "Dental Abnormalities Caused by Novel Compound Heterozygous CTSK
RT   Mutations.";
RL   J. Dent. Res. 94:674-681(2015).
CC   -!- FUNCTION: Closely involved in osteoclastic bone resorption and may
CC       participate partially in the disorder of bone remodeling. Displays
CC       potent endoprotease activity against fibrinogen at acid pH. May
CC       play an important role in extracellular matrix degradation.
CC   -!- CATALYTIC ACTIVITY: Broad proteolytic activity. With small-
CC       molecule substrates and inhibitors, the major determinant of
CC       specificity is P2, which is preferably Leu, Met > Phe, and not
CC       Arg.
CC   -!- SUBCELLULAR LOCATION: Lysosome.
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in osteoclasts
CC       (bones).
CC   -!- DISEASE: Pycnodysostosis (PKND) [MIM:265800]: A rare autosomal
CC       recessive bone disorder characterized by deformity of the skull,
CC       maxilla and phalanges, osteosclerosis, and fragility of bone.
CC       {ECO:0000269|PubMed:10491211, ECO:0000269|PubMed:10878663,
CC       ECO:0000269|PubMed:22822386, ECO:0000269|PubMed:25731711,
CC       ECO:0000269|PubMed:8703060, ECO:0000269|PubMed:9529353}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the peptidase C1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU10088, ECO:0000255|PROSITE-
CC       ProRule:PRU10089, ECO:0000255|PROSITE-ProRule:PRU10090}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U13665; AAA65233.1; -; mRNA.
DR   EMBL; X82153; CAA57649.1; -; mRNA.
DR   EMBL; U20280; AAA95998.1; -; mRNA.
DR   EMBL; S79895; AAB35521.1; -; mRNA.
DR   EMBL; CR541675; CAG46476.1; -; mRNA.
DR   EMBL; AL355860; CAI12795.1; -; Genomic_DNA.
DR   EMBL; AL356292; CAI12795.1; JOINED; Genomic_DNA.
DR   EMBL; AL356292; CAI13649.1; -; Genomic_DNA.
DR   EMBL; AL355860; CAI13649.1; JOINED; Genomic_DNA.
DR   EMBL; CH471121; EAW53516.1; -; Genomic_DNA.
DR   EMBL; BC016058; AAH16058.1; -; mRNA.
DR   CCDS; CCDS969.1; -.
DR   PIR; JC2476; JC2476.
DR   RefSeq; NP_000387.1; NM_000396.3.
DR   UniGene; Hs.632466; -.
DR   PDB; 1ATK; X-ray; 2.20 A; A=115-329.
DR   PDB; 1AU0; X-ray; 2.60 A; A=115-329.
DR   PDB; 1AU2; X-ray; 2.60 A; A=115-329.
DR   PDB; 1AU3; X-ray; 2.50 A; A=115-329.
DR   PDB; 1AU4; X-ray; 2.30 A; A=115-329.
DR   PDB; 1AYU; X-ray; 2.20 A; A=115-329.
DR   PDB; 1AYV; X-ray; 2.30 A; A=115-329.
DR   PDB; 1AYW; X-ray; 2.40 A; A=115-329.
DR   PDB; 1BGO; X-ray; 2.30 A; A=115-329.
DR   PDB; 1BY8; X-ray; 2.60 A; A=16-329.
DR   PDB; 1MEM; X-ray; 1.80 A; A=115-329.
DR   PDB; 1NL6; X-ray; 2.80 A; A/B=115-329.
DR   PDB; 1NLJ; X-ray; 2.40 A; A/B=115-329.
DR   PDB; 1Q6K; X-ray; 2.10 A; A=115-329.
DR   PDB; 1SNK; X-ray; 2.40 A; A=116-329.
DR   PDB; 1TU6; X-ray; 1.75 A; A/B=115-329.
DR   PDB; 1U9V; X-ray; 2.20 A; A=113-329.
DR   PDB; 1U9W; X-ray; 2.30 A; A=113-329.
DR   PDB; 1U9X; X-ray; 2.10 A; A=113-329.
DR   PDB; 1VSN; X-ray; 2.00 A; A=115-329.
DR   PDB; 1YK7; X-ray; 2.50 A; A=115-329.
DR   PDB; 1YK8; X-ray; 2.60 A; A=115-329.
DR   PDB; 1YT7; X-ray; 2.30 A; A=115-329.
DR   PDB; 2ATO; X-ray; 2.00 A; A=115-329.
DR   PDB; 2AUX; X-ray; 2.40 A; A=115-329.
DR   PDB; 2AUZ; X-ray; 2.30 A; A=115-329.
DR   PDB; 2BDL; X-ray; 2.00 A; A=115-329.
DR   PDB; 2R6N; X-ray; 1.95 A; A=113-329.
DR   PDB; 3C9E; X-ray; 1.80 A; A=115-329.
DR   PDB; 3H7D; X-ray; 2.24 A; A/E=115-329.
DR   PDB; 3KW9; X-ray; 1.80 A; A=115-329.
DR   PDB; 3KWB; X-ray; 2.02 A; X/Y=115-329.
DR   PDB; 3KWZ; X-ray; 1.49 A; A=115-329.
DR   PDB; 3KX1; X-ray; 1.51 A; A=115-329.
DR   PDB; 3O0U; X-ray; 1.80 A; A=115-329.
DR   PDB; 3O1G; X-ray; 1.65 A; A=115-329.
DR   PDB; 3OVZ; X-ray; 2.02 A; A=121-329.
DR   PDB; 4DMX; X-ray; 1.70 A; A=115-329.
DR   PDB; 4DMY; X-ray; 1.63 A; A/B=115-329.
DR   PDB; 4N79; X-ray; 2.62 A; A=115-329.
DR   PDB; 4N8W; X-ray; 2.02 A; A=115-329.
DR   PDB; 4X6H; X-ray; 1.00 A; A=115-329.
DR   PDB; 4X6I; X-ray; 1.87 A; A=115-329.
DR   PDB; 4X6J; X-ray; 1.59 A; A=115-329.
DR   PDB; 4YV8; X-ray; 2.00 A; A=115-329.
DR   PDB; 4YVA; X-ray; 1.80 A; A=115-329.
DR   PDB; 5J94; X-ray; 2.60 A; A=107-329.
DR   PDB; 5JA7; X-ray; 1.61 A; A/B=107-329.
DR   PDB; 5JH3; X-ray; 1.75 A; A=107-329.
DR   PDB; 5TDI; X-ray; 1.40 A; A=115-329.
DR   PDB; 5TUN; X-ray; 1.62 A; A=115-329.
DR   PDB; 7PCK; X-ray; 3.20 A; A/B/C/D=16-329.
DR   PDBsum; 1ATK; -.
DR   PDBsum; 1AU0; -.
DR   PDBsum; 1AU2; -.
DR   PDBsum; 1AU3; -.
DR   PDBsum; 1AU4; -.
DR   PDBsum; 1AYU; -.
DR   PDBsum; 1AYV; -.
DR   PDBsum; 1AYW; -.
DR   PDBsum; 1BGO; -.
DR   PDBsum; 1BY8; -.
DR   PDBsum; 1MEM; -.
DR   PDBsum; 1NL6; -.
DR   PDBsum; 1NLJ; -.
DR   PDBsum; 1Q6K; -.
DR   PDBsum; 1SNK; -.
DR   PDBsum; 1TU6; -.
DR   PDBsum; 1U9V; -.
DR   PDBsum; 1U9W; -.
DR   PDBsum; 1U9X; -.
DR   PDBsum; 1VSN; -.
DR   PDBsum; 1YK7; -.
DR   PDBsum; 1YK8; -.
DR   PDBsum; 1YT7; -.
DR   PDBsum; 2ATO; -.
DR   PDBsum; 2AUX; -.
DR   PDBsum; 2AUZ; -.
DR   PDBsum; 2BDL; -.
DR   PDBsum; 2R6N; -.
DR   PDBsum; 3C9E; -.
DR   PDBsum; 3H7D; -.
DR   PDBsum; 3KW9; -.
DR   PDBsum; 3KWB; -.
DR   PDBsum; 3KWZ; -.
DR   PDBsum; 3KX1; -.
DR   PDBsum; 3O0U; -.
DR   PDBsum; 3O1G; -.
DR   PDBsum; 3OVZ; -.
DR   PDBsum; 4DMX; -.
DR   PDBsum; 4DMY; -.
DR   PDBsum; 4N79; -.
DR   PDBsum; 4N8W; -.
DR   PDBsum; 4X6H; -.
DR   PDBsum; 4X6I; -.
DR   PDBsum; 4X6J; -.
DR   PDBsum; 4YV8; -.
DR   PDBsum; 4YVA; -.
DR   PDBsum; 5J94; -.
DR   PDBsum; 5JA7; -.
DR   PDBsum; 5JH3; -.
DR   PDBsum; 5TDI; -.
DR   PDBsum; 5TUN; -.
DR   PDBsum; 7PCK; -.
DR   ProteinModelPortal; P43235; -.
DR   SMR; P43235; -.
DR   BioGrid; 107893; 8.
DR   DIP; DIP-39993N; -.
DR   IntAct; P43235; 3.
DR   STRING; 9606.ENSP00000271651; -.
DR   BindingDB; P43235; -.
DR   ChEMBL; CHEMBL268; -.
DR   DrugBank; DB07592; (1R)-2-METHYL-1-(PHENYLMETHYL)PROPYL[(1S)-1-FORMYLPENTYL]CARBAMATE.
DR   DrugBank; DB07593; 1-(PHENYLMETHYL)CYCLOPENTYL[(1S)-1-FORMYLPENTYL]CARBAMATE.
DR   DrugBank; DB04244; 1-[2-(3-Biphenyl)-4-Methylvaleryl)]Amino-3-(2-Pyridylsulfonyl)Amino-2-Propanone.
DR   DrugBank; DB03405; 1-[N[(Phenylmethoxy)Carbonyl]-L-Leucyl-4-[[N/N-[(Phenylmethoxy)Carbonyl]-/Nl-Leucyl]Amino]-3-Pyrrolidinone/N.
DR   DrugBank; DB02869; 3-amino-5-phenylpentane.
DR   DrugBank; DB07965; 6-(cyclohexylamino)-9-[2-(4-methylpiperazin-1-yl)-ethyl]-9H-purine-2-carbonitrile.
DR   DrugBank; DB07967; 9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE.
DR   DrugBank; DB01858; [1-(4-Fluorobenzyl)Cyclobutyl]Methyl (1s)-1-[Oxo(1h-Pyrazol-5-Ylamino)Acetyl]Pentylcarbamate.
DR   DrugBank; DB03642; Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide.
DR   DrugBank; DB05736; MIV-701.
DR   DrugBank; DB04234; N2-({[(4-Bromophenyl)Methyl]Oxy}Carbonyl)-N1-[(1s)-1-Formylpentyl]-L-Leucinamide.
DR   DrugBank; DB03456; N2-[(benzyloxy)carbonyl]-n1-[(3S)-1-cyanopyrrolidin-3-yl]-l-leucinamide.
DR   DrugBank; DB08594; TERT-BUTYL 2-CYANO-2-METHYLHYDRAZINECARBOXYLATE.
DR   DrugBank; DB04523; Tert-Butyl(1s)-1-Cyclohexyl-2-Oxoethylcarbamate.
DR   GuidetoPHARMACOLOGY; 2350; -.
DR   MEROPS; I29.007; -.
DR   iPTMnet; P43235; -.
DR   PhosphoSitePlus; P43235; -.
DR   BioMuta; CTSK; -.
DR   DMDM; 1168793; -.
DR   EPD; P43235; -.
DR   PaxDb; P43235; -.
DR   PeptideAtlas; P43235; -.
DR   PRIDE; P43235; -.
DR   DNASU; 1513; -.
DR   Ensembl; ENST00000271651; ENSP00000271651; ENSG00000143387.
DR   GeneID; 1513; -.
DR   KEGG; hsa:1513; -.
DR   UCSC; uc001evp.3; human.
DR   CTD; 1513; -.
DR   DisGeNET; 1513; -.
DR   GeneCards; CTSK; -.
DR   HGNC; HGNC:2536; CTSK.
DR   HPA; HPA050346; -.
DR   MalaCards; CTSK; -.
DR   MIM; 265800; phenotype.
DR   MIM; 601105; gene.
DR   neXtProt; NX_P43235; -.
DR   OpenTargets; ENSG00000143387; -.
DR   Orphanet; 763; Pycnodysostosis.
DR   PharmGKB; PA27034; -.
DR   eggNOG; KOG1543; Eukaryota.
DR   eggNOG; COG4870; LUCA.
DR   GeneTree; ENSGT00760000118871; -.
DR   HOGENOM; HOG000230774; -.
DR   HOVERGEN; HBG011513; -.
DR   InParanoid; P43235; -.
DR   KO; K01371; -.
DR   OMA; KHISIHN; -.
DR   OrthoDB; EOG091G0AKT; -.
DR   PhylomeDB; P43235; -.
DR   TreeFam; TF313739; -.
DR   BRENDA; 3.4.22.38; 2681.
DR   Reactome; R-HSA-1442490; Collagen degradation.
DR   Reactome; R-HSA-1474228; Degradation of the extracellular matrix.
DR   Reactome; R-HSA-1592389; Activation of Matrix Metalloproteinases.
DR   Reactome; R-HSA-1679131; Trafficking and processing of endosomal TLR.
DR   Reactome; R-HSA-2132295; MHC class II antigen presentation.
DR   SIGNOR; P43235; -.
DR   ChiTaRS; CTSK; human.
DR   EvolutionaryTrace; P43235; -.
DR   GeneWiki; Cathepsin_K; -.
DR   GenomeRNAi; 1513; -.
DR   PRO; PR:P43235; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143387; -.
DR   CleanEx; HS_CTSK; -.
DR   CleanEx; HS_CTSO; -.
DR   ExpressionAtlas; P43235; baseline and differential.
DR   Genevisible; P43235; HS.
DR   GO; GO:0036021; C:endolysosome lumen; TAS:Reactome.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:BHF-UCL.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005764; C:lysosome; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005518; F:collagen binding; IDA:BHF-UCL.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IDA:BHF-UCL.
DR   GO; GO:0008234; F:cysteine-type peptidase activity; TAS:ProtInc.
DR   GO; GO:0001968; F:fibronectin binding; IPI:BHF-UCL.
DR   GO; GO:0043394; F:proteoglycan binding; IPI:BHF-UCL.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; TAS:Reactome.
DR   GO; GO:0045453; P:bone resorption; IEA:Ensembl.
DR   GO; GO:0030574; P:collagen catabolic process; IDA:BHF-UCL.
DR   GO; GO:0022617; P:extracellular matrix disassembly; TAS:Reactome.
DR   GO; GO:0001957; P:intramembranous ossification; IEA:Ensembl.
DR   GO; GO:1903955; P:positive regulation of protein targeting to mitochondrion; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0006508; P:proteolysis; TAS:ProtInc.
DR   GO; GO:0051603; P:proteolysis involved in cellular protein catabolic process; IDA:BHF-UCL.
DR   GO; GO:1903146; P:regulation of mitophagy; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome.
DR   InterPro; IPR025661; Pept_asp_AS.
DR   InterPro; IPR000169; Pept_cys_AS.
DR   InterPro; IPR025660; Pept_his_AS.
DR   InterPro; IPR013128; Peptidase_C1A.
DR   InterPro; IPR000668; Peptidase_C1A_C.
DR   InterPro; IPR015644; Peptidase_C1A_cathepsin-K.
DR   InterPro; IPR013201; Prot_inhib_I29.
DR   PANTHER; PTHR12411; PTHR12411; 1.
DR   PANTHER; PTHR12411:SF442; PTHR12411:SF442; 1.
DR   Pfam; PF08246; Inhibitor_I29; 1.
DR   Pfam; PF00112; Peptidase_C1; 1.
DR   PRINTS; PR00705; PAPAIN.
DR   SMART; SM00848; Inhibitor_I29; 1.
DR   SMART; SM00645; Pept_C1; 1.
DR   PROSITE; PS00640; THIOL_PROTEASE_ASN; 1.
DR   PROSITE; PS00139; THIOL_PROTEASE_CYS; 1.
DR   PROSITE; PS00639; THIOL_PROTEASE_HIS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Disease mutation; Disulfide bond;
KW   Glycoprotein; Hydrolase; Lysosome; Protease; Reference proteome;
KW   Signal; Thiol protease; Zymogen.
FT   SIGNAL        1     15       {ECO:0000255}.
FT   PROPEP       16    114       Activation peptide.
FT                                /FTId=PRO_0000026295.
FT   CHAIN       115    329       Cathepsin K.
FT                                /FTId=PRO_0000026296.
FT   ACT_SITE    139    139       {ECO:0000250}.
FT   ACT_SITE    276    276       {ECO:0000250}.
FT   ACT_SITE    296    296       {ECO:0000250}.
FT   CARBOHYD    103    103       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    136    177
FT   DISULFID    170    210
FT   DISULFID    269    318
FT   VARIANT      79     79       G -> E (in PKND; dbSNP:rs74315305).
FT                                {ECO:0000269|PubMed:10491211,
FT                                ECO:0000269|PubMed:10878663}.
FT                                /FTId=VAR_015738.
FT   VARIANT     122    122       R -> P (in PKND).
FT                                {ECO:0000269|PubMed:22822386}.
FT                                /FTId=VAR_074023.
FT   VARIANT     146    146       G -> R (in PKND; dbSNP:rs74315302).
FT                                {ECO:0000269|PubMed:8703060}.
FT                                /FTId=VAR_006725.
FT   VARIANT     277    277       A -> V (in PKND; dbSNP:rs74315304).
FT                                {ECO:0000269|PubMed:22822386,
FT                                ECO:0000269|PubMed:9529353}.
FT                                /FTId=VAR_015739.
FT   VARIANT     283    283       Y -> C (in PKND; does not affect protein
FT                                level; does not detect cysteine-type
FT                                endopeptidase activity).
FT                                {ECO:0000269|PubMed:25731711}.
FT                                /FTId=VAR_074024.
FT   VARIANT     309    309       L -> P (in PKND; dbSNP:rs29001685).
FT                                {ECO:0000269|PubMed:10878663}.
FT                                /FTId=VAR_006726.
FT   CONFLICT     46     46       R -> P (in Ref. 3; AAA95998).
FT                                {ECO:0000305}.
FT   HELIX        22     32       {ECO:0000244|PDB:1BY8}.
FT   HELIX        40     66       {ECO:0000244|PDB:1BY8}.
FT   STRAND       70     73       {ECO:0000244|PDB:1BY8}.
FT   STRAND       79     81       {ECO:0000244|PDB:1BY8}.
FT   HELIX        83     89       {ECO:0000244|PDB:1BY8}.
FT   STRAND      102    107       {ECO:0000244|PDB:1BY8}.
FT   HELIX       121    124       {ECO:0000244|PDB:4X6H}.
FT   STRAND      135    137       {ECO:0000244|PDB:3KX1}.
FT   HELIX       139    156       {ECO:0000244|PDB:4X6H}.
FT   HELIX       164    170       {ECO:0000244|PDB:4X6H}.
FT   HELIX       176    178       {ECO:0000244|PDB:4X6H}.
FT   HELIX       182    192       {ECO:0000244|PDB:4X6H}.
FT   STRAND      195    197       {ECO:0000244|PDB:4X6H}.
FT   TURN        198    200       {ECO:0000244|PDB:4X6H}.
FT   HELIX       214    216       {ECO:0000244|PDB:4X6H}.
FT   STRAND      217    219       {ECO:0000244|PDB:4X6H}.
FT   STRAND      223    226       {ECO:0000244|PDB:4X6H}.
FT   HELIX       232    242       {ECO:0000244|PDB:4X6H}.
FT   STRAND      245    249       {ECO:0000244|PDB:4X6H}.
FT   HELIX       254    257       {ECO:0000244|PDB:4X6H}.
FT   STRAND      261    264       {ECO:0000244|PDB:4X6H}.
FT   STRAND      276    286       {ECO:0000244|PDB:4X6H}.
FT   STRAND      289    295       {ECO:0000244|PDB:4X6H}.
FT   STRAND      300    302       {ECO:0000244|PDB:3H7D}.
FT   TURN        303    305       {ECO:0000244|PDB:1AYV}.
FT   STRAND      307    316       {ECO:0000244|PDB:4X6H}.
FT   HELIX       317    319       {ECO:0000244|PDB:4X6H}.
FT   TURN        320    322       {ECO:0000244|PDB:3KX1}.
FT   STRAND      325    328       {ECO:0000244|PDB:4X6H}.
SQ   SEQUENCE   329 AA;  36966 MW;  4677C3C89FF4CE85 CRC64;
     MWGLKVLLLP VVSFALYPEE ILDTHWELWK KTHRKQYNNK VDEISRRLIW EKNLKYISIH
     NLEASLGVHT YELAMNHLGD MTSEEVVQKM TGLKVPLSHS RSNDTLYIPE WEGRAPDSVD
     YRKKGYVTPV KNQGQCGSCW AFSSVGALEG QLKKKTGKLL NLSPQNLVDC VSENDGCGGG
     YMTNAFQYVQ KNRGIDSEDA YPYVGQEESC MYNPTGKAAK CRGYREIPEG NEKALKRAVA
     RVGPVSVAID ASLTSFQFYS KGVYYDESCN SDNLNHAVLA VGYGIQKGNK HWIIKNSWGE
     NWGNKGYILM ARNKNNACGI ANLASFPKM
//
